Stocktwits on MSN
ZVRA stock sinks 23% on EU setback — analyst says risk is 'a headwind, but not insurmountable'
Zevra plans to request a re-examination and will submit a detailed response. ・H.C. Wainwright called the negative opinion on Zevra Therapeutics’ marketing application for arimoclomol “a disappointing ...
A panel of federal health advisers on Thursday narrowly recommended easing access to several peptides popular with wellness ...
This week, Kennedy, who came into his job as Health secretary promising to stop the FDA's "aggressive suppression" of peptides, took a big step toward potentially reversing the agency's position.
The FDA panel is reviewing seven peptides and deciding if they should be added to a list of substances that can be safely ...
On Friday, the advisers are discussing three peptides: ...
A rare condition threatened Baby KJ's life. A team of medical researchers stepped forward with a first-of-its-kind genetic ...
What is ibogaine? The psychoactive drug promoted by Joe Rogan and backed by the Trump administration is being studied for ...
RFK Jr. and many like him, who fear the clearly defined and well-understood proteins in vaccines, are perfectly willing to ...
It is expected that the European Commission will grant the Marketing Authorisation by the end of September 2026.
ASX healthcare stocks fell sharply this week, but TTX could benefit from moves to ease restrictions on peptides in US.
A group of advisers to the Food and Drug Administration voted in favor of allowing pharmacies to compound peptides like BPC-157 and TB-500, which means the hot-button peptides may soon become more ...
Sarcomatrix Therapeutics Corp., a Delaware corporation based in Reno, Nevada, today announced that its investment round is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results